GQGuiming Qin

Guiming Qin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guiming Qin has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Abdulbaset Al-Romaima

    State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, Yunnan, People's Republic of China; University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China

    1 shared publication
  • Jie Feng

    School of Pharmaceutical Science, Guangxi Medical University, Nanning, China

    1 shared publication
  • Shixiong Tang

    The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530007 Guangxi, China

    1 shared publication
  • Xihui Qin

    School of Pharmaceutical Science, Guangxi Medical University, Nanning, 530021 Guangxi, China

    1 shared publication
  • Xiong Guan

    The Eighth People’s Hospital of Nanning, Nanning 530007, China

    1 shared publication
  • Yinan Liao

    School of Pharmaceutical Science, Guangxi Medical University, Nanning, 530021 Guangxi, China

    1 shared publication

Latest Publications

  • Open Access

    Topical Application of Chinese Formula Yeliangen Promotes Wound Healing in Streptozotocin-Induced Diabetic Rats

    by Abdulbaset Al-Romaima, Xiong Guan, Xihui Qin, Yinan Liao, Guiming Qin, Shixiong Tang, Jie Feng

    Diabetic wound is one of the most severe complications of diabetes mellitus (DM). Despite the associated risks of wound healing impairment in diabetes, treatment strategies remain limited. Yeliangen (YLG) is a Chinese formulation mainly composed of the rhizome of Coptis chinensis, the root of Isatis tinctoria, and the leaf of Isatis indigotica. We investigated the wound healing effects of YLG in type 2 diabetic (T2DM) rats, which were induced by intraperitoneal administration of streptozotocin after a high-fat diet for four weeks. full-thickness excisional wounds were created on the dorsal surface of rats and then divided to control (DC), negative (DPJ), positive (DPC), and YLG-treated (DYLG) groups. Rat’s wounds were treated twice daily for 21 days. Wound area and wound contraction were detected on days 0, 3, 7, 14, and 21. Histopathological examinations were performed by H&E staining and immunohistochemistry (IHC). The biochemical parameters, mRNAs, and protein expressions were analyzed through enzyme-linked immunoassays (ELISA), qPCR, and western blot, respectively. Compared with other groups, the histological changes of wound tissue in the DYLG group were improved, and the expressions of CD31, eNOS, and PCNA were significantly upregulated. Besides, YLG significantly reduced the inflammatory factors’ expressions of TNF-α, NF-κB, MMP-9, and IL-1B on days 7, 14, and 21 postwounding. Moreover, YLG induced angiogenesis and neovascularization by significantly increasing the levels of VEGF, TGF-β1, EGF, PDGF, and SDF-1α on days 3, 7, and 14. In conclusion, YLG improved wound healing by reducing inflammation and increasing angiogenesis which may provide an alternative and effective approach for diabetic wound therapy.